J Korean Ophthalmol Soc > Volume 59(6); 2018 > Article
Journal of the Korean Ophthalmological Society 2018;59(6):519-526.
DOI: https://doi.org/10.3341/jkos.2018.59.6.519    Published online June 15, 2018.
Intraocular Pressure Changes in Patients with Retinal Vein Occlusion Treated with Intravitreal Dexamethasone Implant Insertion.
Juno Kim, Sung Jin Lee, Dong Hyun Wang
Department of Ophthalmology, Seoul Hospital, Soonchunhyang University College of Medicine, Seoul, Korea. wismile@schmc.ac.kr
망막정맥폐쇄 환자에서 유리체강 내 덱사메타손 임플란트삽입술 시행 후 안압 변화
김준오⋅이성진⋅왕동현
순천향대학교 의과대학 서울병원 안과학교실
Correspondence:  Sung Jin Lee,
Email: wismile@schmc.ac.kr
Received: 18 January 2018   • Revised: 14 March 2018   • Accepted: 28 May 2018
Abstract
PURPOSE
To investigate the occurrence and increase in intraocular pressure (IOP) over time in patients with retinal vein occlusion treated with dexamethasone intravitreal implants. METHODS: Thirty-two patients who met retreatment eligibility criteria received sequential intravitreal dexamethasone implant insertion for retinal vein occlusion in one eye, and were followed for 36 months (maximum of 10 injections) from February 2011 to March 2017. Patients without follow-up data at each investigation time point were excluded. RESULTS: An IOP increase ≥ 10 mmHg from baseline or an IOP ≥ 25 mmHg occurred in 18.8% of the patients. IOP-lowering medications were used in these patients. The first IOP elevation occurred with a mean of 5.9 months after the first intravitreal dexamethasone implant insertion in the IOP elevation group, and with a mean of 1.5 months after previous intravitreal dexamethasone implant insertion in each IOP elevation event. No patients required laser or incisional glaucoma surgery during the study period. CONCLUSIONS: An increase in IOP occurred in the early period after intravitreal dexamethasone implant insertion, and did not occur in sequential insertion. Although an increase in IOP was a significant side effect of intravitreal dexamethasone implant insertion, the IOP could be controlled with careful observation and use of preliminary and therapeutic anti-ocular hypertensive agents.
Key Words: Intravitreal dexamethasone implant;Retina;Retinal vein occlusion


ABOUT
BROWSE ARTICLES
EDITORIAL POLICY
FOR CONTRIBUTORS
Editorial Office
SKY 1004 Building #701
50-1 Jungnim-ro, Jung-gu, Seoul 04508, Korea
Tel: +82-2-583-6520    Fax: +82-2-583-6521    E-mail: kos08@ophthalmology.org                

Copyright © 2024 by Korean Ophthalmological Society.

Developed in M2PI

Close layer
prev next